Current concepts regarding Graves’ orbitopathy
Journal of Internal Medicine, 2022 AbstractGraves’ orbitopathy (GO) is an orbital autoimmune disorder and the main extrathyroidal manifestation of Graves’ disease, the most common cause of hyperthyroidism. GO affects about 30% of Graves’ patients, although fewer than 10% have severe forms requiring immunosuppressive treatments.
Luigi Bartalena, Maria Laura Tanda
openaire +4 more sources
Muscle tendon elongation with bovine pericardium (Tutopatch®) in patients with Graves' orbitopathy; a prospective, observational, multicentre study. [PDF]
Acta OphthalmolAbstract Purpose Patients with severe ocular motility restriction and/or large angle strabismus due to Graves' orbitopathy (GO) cannot be adequately addressed with conventional strabismus surgery using large muscle recessions. Muscle tendon elongation surgery, using a spacer of bovine pericardium (Tutopatch®) has emerged as a valuable alternative.
Jellema HM +7 more
europepmc +2 more sources
Management of patients with Graves' disease and orbital involvement: role of spectral domain optical coherence tomography [PDF]
, 2018 PURPOSE: To investigate the role of choroidal thickness evaluation with spectral domain optical coherence tomography (SDOCT) and enhanced depth imaging (EDI) technique in the management of patients with Graves' disease and orbitopathy (GO).
Bruscolini, A +7 more
core +1 more source
Microbiome and Graves’ Orbitopathy [PDF]
European Thyroid Journal, 2020 <b><i>Background:</i></b> Studies from animal models of autoimmunity have highlighted the potential importance of microorganisms and their metabolic products in shaping the immune system. <b><i>Summary:</i></b> This review provides an introduction to the current state-of-the-art in microbiome research ...
Giulia, Masetti, Marian, Ludgate
openaire +2 more sources
Active Moderate-to-Severe Graves' Orbitopathy in a Patient With Type 2 Diabetes Mellitus and Vascular Complications [PDF]
, 2019 Background: Graves’ orbitopathy (GO) is the main extrathyroidal manifestation of Graves’ disease (GD). Diabetes mellitus (DM) has been reported to be a risk factor in patients with GO.
Biondi, B +5 more
core +2 more sources
Not All Orbitopathy Is Graves’: Discussion of Cases and Review of Literature
Frontiers in Endocrinology, 2017 IntroductionGraves’ orbitopathy is the extra thyroidal manifestation of Graves’ disease and the most common cause of exophthalmos. It is also known as thyroid-associated orbitopathy (TAO) as it occasionally occurs in euthyroid or hypothyroid patients ...
Neeraja Boddu +4 more
doaj +1 more source
International Journal of Endocrinology, 2015 Purpose. To evaluate the effect of en bloc lateral wall decompression with additional orbital fat resection in terms of exophthalmos reduction and complications. Methods.
Nicole Fichter, Rudolf F. Guthoff
doaj +1 more source
Rituximab Treatment in a Patient with Active Graves’ Orbitopathy and Psoriasis
Türk Oftalmoloji Dergisi, 2017 Management of Graves’ orbitopathy remains an important therapeutic challenge. Current therapeutic modalities are unsatisfactory in about one third of patients.
Tülay Şimşek +3 more
doaj +1 more source
Thyroid-Associated Orbitopathy and Biomarkers: Where We Are and What We Can Hope for the Future. [PDF]
, 2018 Thyroid-associated orbitopathy (TAO) is the most common autoimmune disease of the orbit. It occurs more often in patients presenting with hyperthyroidism, characteristic of Graves' disease, but may be associated with hypothyroidism or euthyroidism.
De Los Angeles Gracia, M. +4 more
core +3 more sources
Inactive Graves’ orbitopathy: to treat or not to treat?
Российский офтальмологический журнал, 2023 Purpose: to evaluate the expediency and efficacy of conservative therapy of patients with inactive stages of Graves’ orbitopathy complicated by optical neuropathy. Materials and methods.
O. G. Panteleeva, F. H. Batyrbekova
doaj +1 more source